SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001437749-21-011755
Filing Date
2021-05-12
Accepted
2021-05-12 07:30:56
Documents
54
Period of Report
2021-03-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q mbrx20210331_10q.htm   iXBRL 10-Q 668755
2 EXHIBIT 31.1 ex_239542.htm EX-31.1 13430
3 EXHIBIT 31.2 ex_239543.htm EX-31.2 13263
4 EXHIBIT 32.1 ex_239544.htm EX-32.1 6596
5 EXHIBIT 32.2 ex_239545.htm EX-32.2 6672
11 moleculinlogoresizedclear.jpg GRAPHIC 19339
  Complete submission text file 0001437749-21-011755.txt   3503135

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA mbrx-20210331.xsd EX-101.SCH 40621
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE mbrx-20210331_cal.xml EX-101.CAL 31006
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE mbrx-20210331_def.xml EX-101.DEF 248362
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE mbrx-20210331_lab.xml EX-101.LAB 230915
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE mbrx-20210331_pre.xml EX-101.PRE 268311
12 EXTRACTED XBRL INSTANCE DOCUMENT mbrx20210331_10q_htm.xml XML 437276
Mailing Address 5300 MEMORIAL DRIVE SUITE 950 HOUSTON TX 77007
Business Address 5300 MEMORIAL DRIVE SUITE 950 HOUSTON TX 77007 713-300-5160
Moleculin Biotech, Inc. (Filer) CIK: 0001659617 (see all company filings)

IRS No.: 474671999 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-37758 | Film No.: 21913455
SIC: 2834 Pharmaceutical Preparations